Thrombosis and bleeding in critical COVID-19 patients: two sides of the same coin

J Cardiovasc Med (Hagerstown). 2021 Sep 1;22(9):723-725. doi: 10.2459/JCM.0000000000001080.

Authors

Eduardo Josué Flores-Umanzor^{1

2}, Levio Quinto^{1

2}, Manuel López-Baamonde^{1

2}, Gala Caixal^{1

2}, Sara Vázquez^{1

2}, Laia Tirapu¹, Guiomar Mendieta¹, Rut Andrea^{1

2}

Affiliations

¹ Acute Cardiac Care Section, Cardiovascular Institute, Hospital Clinic Barcelona.
² IDIBAPS, University of Barcelona, Barcelona, Spain.

PMID: 32858633
DOI: 10.2459/JCM.0000000000001080

No abstract available

Publication types

Case Reports

MeSH terms

Anticoagulants / administration & dosage
Anticoagulants / adverse effects
COVID-19* / blood
COVID-19* / diagnosis
COVID-19* / physiopathology
COVID-19* / therapy
Computed Tomography Angiography / methods
Fibrin Fibrinogen Degradation Products / analysis*
Hematoma* / complications
Hematoma* / diagnostic imaging
Hematoma* / therapy
Heparin* / administration & dosage
Heparin* / adverse effects
Humans
Hypoxia / etiology
Hypoxia / therapy
Lung* / diagnostic imaging
Lung* / pathology
Male
Middle Aged
Patient Care Management / methods
Patient Selection
Pulmonary Embolism* / complications
Pulmonary Embolism* / diagnostic imaging
Pulmonary Embolism* / etiology
Pulmonary Embolism* / therapy
Risk Adjustment / methods
SARS-CoV-2
Treatment Outcome

Substances

Anticoagulants
Fibrin Fibrinogen Degradation Products
fibrin fragment D
Heparin